SINGLE-DOSE PHARMACOKINETICS OF BMS-790052 IN SUBJECTS WITH HEPATIC IMPAIRMENT COMPARED WITH HEALTHY SUBJECTS

被引：0
|
作者：
Bifano, Marc [1 ]
Sevinsky, Heather [1 ]
Persson, A. [2 ]
Chung, Ellen [1 ]
Wind-Rotolo, Megan [1 ]
Hwang, Carey [1 ]
Nettles, Richard [2 ]
Grasela, Dennis M. [1 ]
Marbury, Thomas C. [3 ]
DeMicco, Michael P. [4 ]
Bertz, Richard J. [1 ]
机构：
[1] Bristol Myers Squibb, Res & Dev, Hopewell, NJ USA
[2] Bristol Myers Squibb, Res & Dev, Lawrenceville, NJ USA
[3] Orlando Clin Res Ctr, Orlando, FL USA
[4] Adv Clin Res Inst, Anaheim, CA USA
来源：
HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1004A / 1004A
页数：1
相关论文
共 50 条
  • [1] Single-dose pharmacokinetics and safety of saxagliptin in subjects with hepatic impairment compared with healthy subjects
    Patel, Chirag
    Castaneda, Lorna
    Frevert, Uli
    Li, Li
    Kornhauser, David M.
    Boulton, David W.
    DIABETES, 2008, 57 : A160 - A160
  • [2] Single-dose pharmacokinetics of nefazodone in healthy young and elderly subjects and in subjects with renal or hepatic impairment
    Barbhaiya, RH
    Shukla, UA
    Greene, DS
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 49 (03) : 221 - 228
  • [3] Single-dose pharmacokinetics of quetiapine in subjects with renal or hepatic impairment
    Thyrum, PT
    Wong, YWJ
    Yeh, C
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2000, 24 (04): : 521 - 533
  • [4] Pharmacokinetics of Single-Dose Dolutegravir in HIV-Seronegative Subjects With Moderate Hepatic Impairment Compared to Healthy Matched Controls
    Song, Ivy H.
    Borland, Julie
    Savina, Paul M.
    Chen, Shuguang
    Patel, Parul
    Wajima, Toshihiro
    Peppercorn, Amanda F.
    Piscitelli, Stephen C.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2013, 2 (04): : 342 - 348
  • [5] Single-dose pharmacokinetics of ibrutinib in subjects with varying degrees of hepatic impairment
    de Jonga, Jan
    Skee, Donna
    Hellemans, Peter
    Jiao, James
    de Vries, Ronald
    Swerts, Dominique
    Lawitz, Eric
    Marbury, Thomas
    Smith, William
    Sukbuntherng, Juthamas
    Mannaert, Erik
    LEUKEMIA & LYMPHOMA, 2017, 58 (01) : 185 - 194
  • [6] Single-dose pharmacokinetics of methadone in healthy subjects
    Wolff, K
    Hay, AWM
    Shires, S
    Feely, M
    Calvert, R
    RostamiHodjegan, A
    Tucker, GT
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 42 (05) : P670 - P670
  • [7] BMS-790052 HAS NO EFFECT ON THE PHARMACOKINETICS OF A COMBINED ORAL CONTRACEPTIVE CONTAINING ETHINYL ESTRADIOL AND NORGESTIMATE IN HEALTHY FEMALE SUBJECTS
    Bifano, Marc
    Sevinsky, Heather
    Persson, A.
    Hwang, Carey
    Kandoussi, Hamza
    Jiang, Hao
    Grasela, Dennis M.
    Bertz, Richard J.
    HEPATOLOGY, 2011, 54 : 991A - 992A
  • [8] SINGLE-DOSE SAFETY AND PHARMACOKINETICS OF APIXABAN IN SUBJECTS WITH MILD OR MODERATE HEPATIC IMPAIRMENT
    Frost, C. E.
    Yu, Z.
    Wang, J.
    Li, T.
    Zeigler, C.
    Schuster, A.
    Ly, V.
    Zhang, D.
    LaCreta, F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S34 - S34
  • [9] Single-dose pharmacokinetics of citalopram in patients with moderate renal insufficiency or hepatic cirrhosis compared with healthy subjects
    Joffe, P
    Larsen, FS
    Pedersen, V
    Ring-Larsen, H
    Anes-Jorgensen, T
    Sidhu, J
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (03) : 237 - 242
  • [10] Single-dose pharmacokinetics of citalopram in patients with moderate renal insufficiency or hepatic cirrhosis compared with healthy subjects
    P. Joffe
    F. S. Larsen
    V. Pedersen
    H. Ring-Larsen
    T. Aaes-Jørgensen
    J. Sidhu
    European Journal of Clinical Pharmacology, 1998, 54 : 237 - 242
12345